Publications by authors named "Rafael E Sanchez-Pupo"

Immunotherapies for malignant melanoma seek to boost the anti-tumoral response of CD8 T cells, but have a limited patient response rate, in part due to limited tumoral immune cell infiltration. Genetic or pharmacological inhibition of the pannexin 1 (PANX1) channel-forming protein is known to decrease melanoma cell tumorigenic properties in vitro and ex vivo. Here, we crossed Panx1 knockout (Panx1) mice with the inducible melanoma model Braf, Pten, Tyr::CreER (BPC).

View Article and Find Full Text PDF

The channel-forming glycoprotein PANX3 functions in cutaneous wound healing and keratinocyte differentiation, but its role in maintaining skin homeostasis through aging is not yet understood. We found that PANX3 is absent in newborn skin but becomes upregulated with age. We characterized the skin of global Panx3-knockout (KO) mice and found that KO dorsal skin showed sex differences at different ages but generally had reduced dermal and hypodermal areas compared with age-matched controls.

View Article and Find Full Text PDF

Pannexins (PANX) are a family of three channel-forming membrane glycoproteins expressed in the skin. Previous studies have focused on the role of PANX1 and PANX3 in the regulation of cellular functions in skin cells while PANX2, the largest member of this protein family, has not been investigated. In the current study, we explored the temporal PANX2 expression in murine skin and found that one splice variant () tends to be more abundant at the protein level and is continuously expressed in developed skin.

View Article and Find Full Text PDF

Background: Pannexin 3 (PANX3) is a channel-forming glycoprotein that enables nutrient-induced inflammation in vitro, and genetic linkage data suggest that it regulates body mass index. Here, we characterized inflammatory and metabolic parameters in global Panx3 knockout (KO) mice in the context of forced treadmill running (FEX) and high-fat diet (HFD).

Methods: C57BL/6N (WT) and KO mice were randomized to either a FEX running protocol or no running (SED) from 24 until 30 weeks of age.

View Article and Find Full Text PDF

Pannexin 1 (PANX1) is a glycoprotein that forms large pore channels capable of passing ions and metabolites such as ATP for cellular communication. PANX1 has been implicated in many diseases including breast cancer and melanoma, where inhibition or deletion of PANX1 reduced the tumorigenic and metastatic properties of the cancer cells. We interrogated the effect of single amino acid changes in various PANX1 domains using naturally occurring variants reported in cancer patient tumors.

View Article and Find Full Text PDF
Article Synopsis
  • Pannexin 1 (PANX1) is a glycoprotein found in various tissues, including skin, and forms channels that let ions and small molecules like ATP pass through.
  • The study reveals that PANX1 is frequently expressed in human melanoma tumors and reducing its levels or blocking its function leads to decreased cell growth and increased melanin production in melanoma cell lines.
  • PANX1 appears to influence tumor growth and progression by affecting signaling pathways, particularly the Wnt/β-catenin pathway, highlighting its potential as a target for melanoma treatment.
View Article and Find Full Text PDF

Pannexins (Panx1, 2, 3) are channel-forming glycoproteins expressed in mammalian tissues. We previously reported that N-glycosylation acts as a regulator of the localization and intermixing of Panx1 and Panx3, but its effects on Panx2 are currently unknown. Panx1 and Panx2 intermixing can regulate channel properties, and both pannexins have been implicated in neuronal cell death after ischemia.

View Article and Find Full Text PDF